Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock
Pierre‐François Laterre(Cliniques Universitaires Saint-Luc), Hans‐Christian Thorsen‐Meyer(University of Copenhagen), Grégoire Müller(Centre hospitalier régional d'Orléans), Anders Perner(Unknown), Scott Berry(Queen's University), Steven M. Opal(Brown University), Peter Pickkers(Radboud University Nijmegen), Sine Wichmann(Bispebjerg Hospital), Pierre Asfar(Centre Hospitalier Universitaire d'Angers), Thierry Dugernier(Clinique Saint Pierre), Allan Blemings(Ferring Pharmaceuticals (Denmark)), Bruno Mégarbane(Assistance Publique – Hôpitaux de Paris), Morten H. Bestle(University of Copenhagen), Margot Vander Laenen(Ziekenhuis Oost-Limburg), Roger Lewis(UCLA Medical Center), Todd Graves(Abington Memorial Hospital), Xavier Wittebole(Cliniques Universitaires Saint-Luc), Johan Decruyenaere(Ghent University Hospital), Cédric Bruel(Hôpital Paris Saint-Joseph), Jean‐Pierre Quenot(Inserm), Jean‐Paul Mira(Hôpital Cochin), Bodil Steen Rasmussen, Bruno François(Inserm), Karsten Jacobsen(Ferring Pharmaceuticals (Denmark)), James A. Russell(Northwestern University), Isabelle Vinatier(Roche (France)), Kenneth Krell(Eastern Idaho Technical College), Emmanuelle Mercier(Centre Hospitalier Universitaire de Tours), Marianne Vang, Philippe Vignon(Université de Limoges), N. Brulé(Centre Hospitalier Universitaire de Nantes), Donald M. Yealy(MACOM (United States)), A. Dive(CHU Dinant Godinne UCL Namur), Jan E. Carlsen, Jean‐Yves Lefrant(Centre Hospitalier Universitaire de Nîmes), Anne Louise Kjølbye(Ferring Pharmaceuticals (Denmark)), Derek C. Angus(MACOM (United States)), Nis A. Windeløv(Ferring Pharmaceuticals (Denmark))
Cited by 141
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
|New England Journal of Medicine|2001|6.1k